Intuitive Surgical Logo
US46120E6023
888024
ISRG

Intuitive Surgical

Caricamento quotazioni...

Previsioni

Il prezzo obiettivo medio degli analisti è 439,97 € (+9,32%). La mediana è 453,70 € (+12,73%).

Acquista
  40
Mantieni
  12
Vendi
  5

Discussioni nella community

Non ci sono ancora discussioni su questo asset.

Avvia discussione

  • Intuitive Surgical impresses with quarterly results and offers further upside potential

    Intuitive Surgical reported third-quarter revenue growth of 22% and an increase in procedures of about 15%. Analysts see tailwinds from the new da Vinci 5 and sustained demand in parts of Europe; Baird raised its price target to $550. The stock shows relative strength, is poised to break above $458, and market experts attribute roughly 25% more upside to the shares. » Altro su deraktionaer.de


  • Intuitive Surgical back at yearly high after Q3 numbers – stock rebounds after sell-off

    Intuitive Surgical beat revenue and earnings expectations in the third quarter, pushing the share price back up after a temporary pullback of around ten percent. The stock outperformed the market and briefly reached its highest level since May, sustainably breaking above the 200-day moving average. Analysts view the pullback as a buying opportunity despite concerns about comparison effects and growth worries in the U.S. » Altro su deraktionaer.de


  • Intuitive Surgical beats expectations, stock falls after $450m settlement

    Intuitive Surgical reported third-quarter revenue up 22% to $3.05 billion and adjusted earnings per share of $3.00, both well above analysts’ estimates. Procedures using surgical robots rose 15% and the installed base of Da‑Vinci systems topped 12,000 units for the first time. Despite the strong results, the stock sank by just over ten percent at one point after the company said it will pay a $450 million settlement. Intuitive holds $6.8 billion in cash and announced share buybacks of about $2.94 billion. » Altro su deraktionaer.de


  • Intuitive Surgical ahead of quarterly results: US procedures and guidance in focus

    Intuitive Surgical will report third-quarter results on Tuesday after the US market close. Analysts expect revenue of $2.91 billion and adjusted earnings per share of $2.65. Key for the stock is whether management classifies the slowed growth in Da Vinci procedures in the US as temporary and raises the full-year guidance; the shares are currently about 30% below their 52-week high and just under the 200-day moving average. Competitive pressure from Stryker and CMR Surgical is cited as an additional risk factor. » Altro su deraktionaer.de


  • Intuitive Surgical: growth slows, outlook remains confirmed

    At the Wells‑Fargo conference, Intuitive Surgical reported a slowdown in growth of U.S. procedure volumes but reaffirmed its guidance for global procedure growth of 13.5–15.5% and expects results near the midpoint. The company reported robust revenue, margin and free‑cash‑flow growth in the first half and highlighted support from system upgrades, the launch of the da Vinci 5, expansion into ambulatory surgery centers, and AI and software offerings. Competitive pressure from new market entrants and challenges in China, as well as a decline in bariatric procedures, are cited as headwinds; the operating margin target remains 35–40% and significant share buybacks have been carried out. » Altro su de.investing.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, Intuitive Surgical ha registrato ricavi pari a 2,69 Mld € e un utile netto di 461,55 Mln €
(EUR) settembre 2026
YoY
Ricavi 2,69 Mld 26,09%
Utile lordo 1,84 Mld 29,90%
Utile netto 461,55 Mln 23,11%
EBITDA 590,1 Mln 31,79%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
139,53 Mld €
Numero di azioni
346,64 Mln
Massimo/minimo a 52 settimane
547,96 € - 298,14 €
Dividendi No
Beta
1,44
Rapporto P/E
53,00
Rapporto PEG
5,99
Rapporto P/B
9,68
Rapporto P/S
13,28

Profilo aziendale

Intuitive Surgical, Inc. sviluppa, produce e commercializza prodotti che consentono a medici e fornitori di servizi sanitari di migliorare la qualità e l'accesso alle cure minimamente invasive negli Stati Uniti e a livello internazionale. L'azienda offre il sistema chirurgico da Vinci, che consente interventi chirurgici complessi mediante un approccio minimamente invasivo; e il sistema endoluminale Ion, che estende la sua offerta commerciale dalla chirurgia alle procedure diagnostiche, consentendo biopsie polmonari minimamente invasive. Fornisce inoltre una gamma di strumenti per suturazione meccanica, energia e strumentazione di base per i suoi sistemi chirurgici; percorsi di apprendimento progressivi a supporto dell'utilizzo della sua tecnologia; una serie di servizi per i clienti, tra cui assistenza, installazione, riparazione e manutenzione; e capacità digitali integrate che offrono soluzioni unificate e connesse, semplificando le prestazioni per gli ospedali con approfondimenti che potenziano i programmi. La società è stata costituita nel 1995 ed ha sede a Sunnyvale, California.

Nome
Intuitive Surgical
CEO
David J. Rosa
Sede centrale Sunnyvale, ca
Stati Uniti
Sito web
Settore
Sanità
Industria
Tecnologia sanitaria
Quotazione in borsa
10/08/2023
Dipendenti 17.021

Simboli di borsa

Borsa Simbolo
NASDAQ
ISRG
London Stock Exchange
0R29.L
XETRA
IUI1.DE
Frankfurt
IUI1.F
Düsseldorf
IUI1.DU
Hamburg
IUI1.HM
Milan
1ISRG.MI
London
0R29.L
SIX
ISRG.SW
München
IUI1.MU
Wien
ISRG.VI
🍪

Parqet  usa i cookie. Scopri di più